U.S. markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.33-2.56 (-6.42%)
At close: 4:00PM EDT

37.33 0.00 (0.00%)
After hours: 4:02PM EDT

Sign in to post a message.
  • T
    Tad
    $ARWR conversation
    from twitter: $arwr $ions discontinuation of ENaC program for more promising pulm targets due to pre-clin LT tox finding. buried in the earnings call, not in the press release, nor in the slide deck. classic.
  • C
    Crazy Man
    This company is hard to watch. Have had for years and keep waiting and hoping that something in their pipeline will be a catalyst to a higher price. Ughh!!!
  • C
    Chevy
    Ionis Pharmaceuticals Is Maintained at Underweight by Morgan Stanley
    8:36 am ET May 6, 2021 (Dow Jones) Print

    Ratings actions from Benzinga: https://www.benzinga.com/stock/IONS/ratings


    2021-05-06 12:36:00 GMT DJ Ionis Pharmaceuticals Price Target Cut to $35.00/Share From $38.00 by Morgan Stanley


    Ratings actions from Benzinga: https://www.benzinga.com/stock/IONS/ratings
  • R
    Rico D
    What are you bears gonna say when overwhelmingly positive tofersen and MAPTRx (BIIB080) data are released later this year, especially tofersen because it’s Phase 3? Those data releases should cause the entire neuro pipeline to be revalued higher.
  • b
    btrane
    I posted on Investorvillage for a very long time and wrote that years ago. And it's still true. Bad always follows bad. I'm sorry to have to say it but after watching today's action it makes perfect sense. Crooke made his money and shamelessly pumped this stinkier for decades and other than SMA--nothing. And that will probably be pushed aside by better medicines at some point. Good luck.
  • Y
    Y
    ENaC-Rx bites the dust because they need to concentrate on other drugs? so frustrated with answers from this mgmt....dropped about 5% and below $40.
  • E
    Eric
    $10 FAIR VALUE !!!$Ion Twitter BatLadyBoy spreading lies all these years.His MD/PhD from #$%$ school is a Joke !
    Bearish
  • c
    charles
    This company has made all sorts of strategic mistakes, yet it pays a women ( Lynne, Parshal ) over $1 Million a year for strategic advise, this is a sorry looking inept management that constantly has and is padding itself on the back while doing a very poor job.
  • M
    Marc
    IONS' share price has now fallen to the level it was at in November of 2013. I'm not selling any shares, but I'm really disappointed in this management team.
  • S
    Scott
    While I don't blindly follow ARK trades, ARK has been buying hundreds of thousand of shares almost daily for the past couple weeks. Would be interesting to hear their bullish take o IONS. I've owned IONS in the past, sold at much higher levels, and I know is the company is much stronger today than when I sold it in the high-$50's.
  • R
    RL
    Charles, I find it hard to feel sorry for you after all of my antisense side effect facts to you and your parents & grand parents since 1996. Yes, you're family got taken for decades but don't blame you know who and the secretary. Ok, you got plucked and skinned a nice one. Antisense has always been great for targeting thousands of targets and always having approx. 100 + in the bin. All failed due to side effects. If, I couldn't do it by 2000, then , the future would just be bait. It was and the folks inside knew it all along. Sorry. There is an higher power !

    DARKOUTTONIGHT.
  • c
    charles
    Regardless of managements mishandlings, like starting AKcea and then taking credit for shutting it down, the stock is undervalued, a lot of partners have paid them a lot of upfront money for the programs they are running, if you subtract cash from market cap, this is an undervalued stock. I just hope that puppet board gets rid of deadbeats on the management including Mr. Crooke himself.
  • Y
    Yahoo Finance Insights
    Ionis Pharmaceuticals is down 7.05% to 39.02
  • M
    Mediagaslightingyou
    buy today...sell soon for 55-60 bucks...rinse, repeat
  • o
    ottcschmidlap
    so much for the vaunted pipeline---sell the company
  • R
    Rico D
    Biogen just reported $521 mil in Spinraza sales for the first quarter.
  • C
    Crazy Man
    They continue to disappoint
  • Y
    Y
    As much as I dislike/disagree with IONS management, I am buying more at $36.36, this should bear a 25%-35% profit in 6 months.....with positive Tofersen Phase 3 results.
  • Y
    Yahoo Finance Insights
    Ionis Pharmaceuticals is down 7.06% to 37.08
  • V
    ValueForAll
    Close to multi year lows, one of the widest pipelines in the industry, partnering with the Pharma industry whales, narrow moat with positive moat trend (Morningstar). You know what, I'm buying at that levels and going to hold for years